SlideShare a Scribd company logo
CASE PRESENTATION
Afreen Nasir
PATIENT DEMOGRAPHY
IP NO. : 101901765 Age/sex : 42 years female Department : unit M 1
Ward : 4th DOA : 21/10/19 DOD : 25/10/19
COMPLAINTS ON ADMISSION
• C/o high grade fever since 3 days , involuntary movement since 1 day , generalized weakness
since morning, seizure 1 episode in morning , fever since yesterday.
HISTORY OF PRESENT ILLNESS
• H/o fever with regur , chill from past 3 days , headache since 3 days , associated with blurred
vision
• multiple joints pain since 6 years , deviation of angle of mouth ,ulceration in mouth
• Bluish / black discolouration of digits on exposure to cold
• Cheat pain , breathlessness , palpitation, cough yellowish sputum
• H/o fall & LOC 2 hrs back , H/o 1 episode of GTCM today 23 min ago – attenders found her
unconscious at 6 am .
• H/o tongue bite +
PATIENT HISTORY
• Past medical history : Not K/C/O HTN , hypothyroidism ,k/c/o mixed connective tissue
disorder since 6 years with Raynaud’s phenomenon.
• Family history : Nothing significant
• Medication history :
• Social history : Diet – Mixed Sleep : N Appetite : N Bowel-Bladder : N
• Allergy : NKA
Drug Route Dose Frequency Duration Indication
T. Methotrexate P/O Not specified Not specified Not specified Treat MCTD
T. Prednisone P/O 10mg Once daily ’’ ’’
GENERAL PHYSICAL EXAMNATION
• Vital signs ( 21/10/19)
BP: 150/90 mmHg HR : 100 bpm RR : 20 breaths/min SPO₂ : 99% RA
• Patient is conscious oriented to T/P/P
• PICCKLE : absent
• Muscle tenderness +
SYSTEMIC EXAMINATION (12:30 pm)
CVS : S1S2 +
CNS : drowsy , pupil : 2mm (both R &L ) , Patellar Tendon Reflex(PTR) : 2 + , HMF : + , Plantar :↓,
Reflex : 2+ 2+ Power of both limbs : 5 5 Plantar B/L withdrawal
2+ 2+ 5 3/5
RS : B/L NVBS +
PA : soft non tender
PROVISIONAL DIAGNOSIS
• Δes Cholelithiasis
LABORATORY EXAMINATION
Tests performed 21/10/19 22/10/19 Normal values
Hemogram
Hgb 8.9 9.1 F= 12.3-15.5 g/dL
PCV 28.5 29 F = 36-45%
RBC 4.21 F = 3.5 – 4.5 × 10⁵ / mm³
Platelets 2.5 2.89 1.5-4.5 lakhs/mm³
Reticulocyte Count 0.321 0.5 – 2.5 %
MCH 21 27-32 pg / cell
MCV 70 80-96 fL
MCHC 30 33 – 35.5 g/dL
ESR 45 F= 1-20 mm /hr
CRP 5.9 3 mg/L
WBC 16000 10530 4000-11000/mm³
Neutrophils 90 89 45-73%
Eosinophils 01 01 0-4%
Lymphocytes 04 08 20-40%
Tests performed 21/10/19 22/10/19 Normal values
Basophils 00 00 0-1 %
Monocytes 05 02 2-8%
Folate 20.8 5 - 25 mcg/L
Vit B12 134 180- 914 pg/ml
Ferritin 21.7 F= 11-307 ng/ml
Transferrin Saturation 6.47 20-50%
Transferrin 289 200 – 300 mg/dL
UIBC 313 112-346 microgram/dL
TIBC 334 250-450 microgram/dL
Sr.Iron 21.4 F= 37- 145 microgram / dL
TFT
TSH 1.81 0.25 – 6.7 milli unit /L
FT3 1.38 2.3-4.1 pg/mL
FT4 0.75 2.45 – 4.25 pg/ml
LFT
ALP 59 30-120 unit/L
Tests performed 21/10/19 Normal values
GGT 14 1-94 U/L
Total bilirubin 0.4 Up to 1.2 mg/L
Direct bilirubin 0.1 0.2 mg/dL
SGOT/AST 29 10-35 U/L
SGPT /ALT 26 <35 U/L
Albumin 8.9 3.5-5.5g/dL
Globulin 3.2 2.5-4.5 g/dL
A/G ratio 1:1 1 – 5:1
T. Protein 6.7 6.6 – 8.7 g/dL
RFT
S. creatinine 0.9 F= 0.5-0.9 mg/dL
BUN 2.9 7-20 mg/dl
Sr. Sodium 134 136-145 mEq/L
Sr .Potassium 3.4 3.5 – 5.1 mEq/L
Sr. Chloride 102 97-114 mEq/L
Sr. Calcium 8.3 8.5 – 10.5 mg/dL
Tests performed 21/10/19 22/10/19 Normal values
Biochemistry
FBS 115 75-110 mg/dL
LDH 28 F= 135 -214 U/L
GRBS 133 108 <200 mg/dL
FINAL DIAGNOSIS
• Patient is diagnosed with MCTD , hypothyroidism ,hypertension, seizure disorder ( new onset
, generalized tonic clonic seizure ) , cholelithiasis , microcytic hypochromic anemia of chronic
disease with neutrophilia.
TREATMENT GOALS
• Patient specific –
-Improve QOL
-Selecting cost effective medicine & minimizing side effects of medicines
• Disease specific –
- Achieve normal thyroid function
- Prevent progression of edema in brain before it damage brain
- To bring electrolytes level to normal
- To reduce breathlessness , chest pain , abdomen pain , body pain , headache
- To normalize the raised body temp.
- Reduce episodes of seizure.
TREATMENT CHART
Medicine
prescribed
Dose Freq Route 21/
10
22/
10
23/
10
24/
10
25/
10
26/
10
Indications
T. Amlong ( AMLODIPINE) 5mg 0-0-1 P/O + + + + + + CCB: antihypertensive
T. PREDNISOLONE 40mg 1-0-0 ’’ + + + + 60
mg
60
mg
Treat breathlessness
Inj. Dexoma
(DEXAMETHASONE
PHOSPHATE)
10mg/
ml
1-1-1 IV + + + + 1-0-
1
1-0-
1
Corticosteroid – treat cerebral
edema
Inj . PANTOPRAZOLE 40mg 1-0-0 IV + + + + 1-0-
1
80
mg
1-0-
1
80
mg
PPI
T. Thyronorm ( THYROXINE
SODIUM)
50mcg 1-0-0 P/O + + + + + + Treat hypothyroidism
T. SILDENAFIL 20mg 1-1-1 ’’ + + + + + + Treat Raynaud’s phenomena
Inj. Xone (CEFTRIAXONE) 1g 1-0-1 IV + + + + + + Antibiotic for respiratory inf.
Inj. MANNITOL 100ml 1-0-1 ’’ + + + + + + Diuretic – treat cerebral edema
Inj. Levipil (LEVETIRACETAM) 500ml 1-1-1 ’’ + + + + + + Antiepileptic
Medicine
prescribed
Dose Freq Route 21/
10
22/
10
23/
10
24/
10
25/
10
26/
10
Indications
T. Chymoral Forte (TRYPSIN-
CHYMOTRYPSIN)
1,00,000
armour
units (T&C
ratio 6:1)
1-0-1 P/O + + + Anti-inflammatory,
analgesic
T.CETIRIZINE 10mg 0-0-1 ’’ + + + Antihistimine
T. FERROUS SULPHATE &
FOLIC ACID
200mg /
5mg
1-0-1 ’’ + + + Iron & folic acid
supplement to treat anemia
Inj. VitB12 (
METHYLCOBALAMINE)
1500mcg OD IV + + + Vit B12 supplement to treat
anemia
T.Cal vitD3 (CALCIUM
CARBONATE &
CHOLECALCIFEROL)
250mg/12
5 IU
0-1-0 P/O + + Calcium supplement , treat
hypothyroidism
T. METHOTREXATE 15mg Once
weekly
P/O + Treat MCTD
T. NAPROXEN 500mg Stat P/O + NSAID : Analgesic
PROGRESS CHART
Date Time PR
(bpm)
BP
(mmHg)
SPo2
%
Notes Complaints
21/10 6 AM 1 epi GTCS ,lasting 2-3 min , LOC
for 10 min, H/o tongue bite
12:30
pm
77 150/90 96 CVS : S1S2 + , RS: B/L NVBS +
CNS: Pupil = 2mm both eyes , Plantar
↓ , PTR : 2+
4:10
pm
90 ’’ 98 Pupil reactive , Muscle tenderness +
Power of both limbs : 5 5
5 3/5
CT brain edema cerebral
Reflex : 2+ 2+
2+ 2+
Plantar B/L withdrawal
1 Epi seizure
22/10 132/80 98 RR: 20 breaths/min , Pupil reactive
Plantar ↓ , Power of limbs 5 5
5 5
Date PR
(bpm)
BP
(mmHg)
SPo2
%
Notes Complaints
23/10 70 128/72 98 B/L pupil reactive , B/L plantar reflex
Cytology report : CSF 2ml colourless clear , cell count = 02
cells/mm³
24/10 68 110/80 98 RR: 20 breaths/min , Power : 5 5
5 5
Abdomen pain
25/10 69 110/70 97 Power : 5 5
5 5
26/10 68 120/70 98 RR: 18 breaths/m , CVS: S1S2 + non murmur , CNS : HMF +, Power
of limbs : 5 5
5 5
CLINICAL PHARMACIST NOTES / INTERVENTION
Drug – drug interaction :
• Contraindicated – Ceftriaxone + CaCO₃
• Serious(use alternatives) : Naproxen ↑level of MTX by ↓ renal clearance causes
hematologic & GI toxicity
• Monitor closely –
- CaCO₃ ↓ effect of Amlodipine
- Dexamethasone ↓ effect of Sildenafil , Prednisolone
- Pantoprazole ↑level of MTX by ↓ renal clearance
ADVICE TO DOCTOR:
• Patient still has episodes of seizure which may further decrease Ca level in body , so can we
include T. Calcium & Vit D3 in discharge medicine prescribed.
DISCHARGE MEDICATION
Medication prescribed Dose Frequency Route Duration Possible side effect
T. PREDNISONE 60 mg 1-0-0 P/O 7 days Weight gain, allergies, vertigo
T. Amlong ( AMLODIPINE) 5mg 1-0-1 ’’ ’’ Skin rash , abd pain , headache
T. Levipil (LEVETIRACETAM) 500mg 1-1-1 ’’ ’’ Headache , lack of energy, fatigue
T. METHOTREXATE 15mg Once
weekly
’’ ↓appetite , gingivitis, skin redness
T. SILDENAFIL 20mg 1-1-1 ’’ ’’ Headache , insomnia, dizziness
T . PANTOPRAZOLE 40mg 1-0-0 ’’ ’’ Headache , abd pain ,facial edema,rash
T. Thyronorm ( THYROXINE SODIUM) 50mcg 1-0-0 ’’ Irregular heart beat, anxiety , diarrhea
T. FERROUS SULPHATE & FOLIC ACID 200mg /
5mg
1-0-1 ’’ Dark colour stool , constipation
Zytee oral 10 ml gel ( CHOLINE
SALICYLATE+ LIGNOCAINE
HYDROCHLORIDE + BENZALKONIUM
CHLORIDE)
9.0%w/v
+
2.0%w/v
+
0.02%w/
v
Itching , burning
PATIENT COUNSELLING
• Disease
• Medication
• Diet
• Lifestyle modification

More Related Content

Similar to Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( new onset , generalized tonic clonic seizure ) , cholelithiasis , microcytic hypochromic anemia of chronic disease with neutrophilia.

Cva case stroke
Cva case strokeCva case stroke
Cva case stroke
Umme Habeeba A Pathan
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
Akshaya M
 
Case Presentation on Venous Thromboembolism.pptx
Case Presentation on Venous Thromboembolism.pptxCase Presentation on Venous Thromboembolism.pptx
Case Presentation on Venous Thromboembolism.pptx
Joel M Johns
 
Uti with renal caliculi with type2 dm
Uti with renal caliculi with type2 dmUti with renal caliculi with type2 dm
Uti with renal caliculi with type2 dm
surya720
 
FARM ANALYSIS - Pharm. D.pptx
FARM ANALYSIS - Pharm. D.pptxFARM ANALYSIS - Pharm. D.pptx
FARM ANALYSIS - Pharm. D.pptx
VINEETH VIDHYASAGAR P
 
Systemic corticosteroids in the treatment of acute exacerbations of copd
Systemic corticosteroids in the treatment of acute exacerbations of copdSystemic corticosteroids in the treatment of acute exacerbations of copd
Systemic corticosteroids in the treatment of acute exacerbations of copd
Choying Chen
 
Inpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle CriscoInpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle Crisco
Kyle Crisco
 
Benigh prostatic hyperplasia
Benigh prostatic hyperplasiaBenigh prostatic hyperplasia
Benigh prostatic hyperplasia
Vivian Barrera
 
Laporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptxLaporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptx
YuyunRasulong1
 
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASESAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SaiDeepakS1
 
AKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptxAKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptx
DrHarsh Saxena
 
Case Presentation on Diabetes Mellitus complications
Case Presentation on Diabetes Mellitus complicationsCase Presentation on Diabetes Mellitus complications
Case Presentation on Diabetes Mellitus complications
ShivankAgrawal5
 
Chronic calcific pancreatitis
Chronic calcific pancreatitisChronic calcific pancreatitis
Chronic calcific pancreatitis
devoju himaja
 
Case membranous nephropathy
Case membranous nephropathyCase membranous nephropathy
Case membranous nephropathy
Dipesh Tamrakar
 
Mx of TB.pptx
Mx of TB.pptxMx of TB.pptx
Mx of TB.pptx
JAYDANENJEYAN1
 
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
Dr. Ajita Sadhukhan
 
Mr. Kannan
Mr. KannanMr. Kannan
Mr. Kannan
Sujay Iyer
 
Case presentation on hemiplegia
Case presentation on hemiplegiaCase presentation on hemiplegia
Case presentation on hemiplegia
Vigneswari Paladugu
 
Effusions Explored
Effusions ExploredEffusions Explored
Effusions Explored
Effusions ExploredEffusions Explored
Effusions Explored
gueste19bfb0
 

Similar to Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( new onset , generalized tonic clonic seizure ) , cholelithiasis , microcytic hypochromic anemia of chronic disease with neutrophilia. (20)

Cva case stroke
Cva case strokeCva case stroke
Cva case stroke
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Case Presentation on Venous Thromboembolism.pptx
Case Presentation on Venous Thromboembolism.pptxCase Presentation on Venous Thromboembolism.pptx
Case Presentation on Venous Thromboembolism.pptx
 
Uti with renal caliculi with type2 dm
Uti with renal caliculi with type2 dmUti with renal caliculi with type2 dm
Uti with renal caliculi with type2 dm
 
FARM ANALYSIS - Pharm. D.pptx
FARM ANALYSIS - Pharm. D.pptxFARM ANALYSIS - Pharm. D.pptx
FARM ANALYSIS - Pharm. D.pptx
 
Systemic corticosteroids in the treatment of acute exacerbations of copd
Systemic corticosteroids in the treatment of acute exacerbations of copdSystemic corticosteroids in the treatment of acute exacerbations of copd
Systemic corticosteroids in the treatment of acute exacerbations of copd
 
Inpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle CriscoInpatient Case Presentation. Kyle Crisco
Inpatient Case Presentation. Kyle Crisco
 
Benigh prostatic hyperplasia
Benigh prostatic hyperplasiaBenigh prostatic hyperplasia
Benigh prostatic hyperplasia
 
Laporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptxLaporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptx
 
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASESAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
SAI DEEPAK CASE STUDY ON CHRONIC KIDNEY DISEASE
 
AKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptxAKI IN CIRRHOSIS 1.pptx
AKI IN CIRRHOSIS 1.pptx
 
Case Presentation on Diabetes Mellitus complications
Case Presentation on Diabetes Mellitus complicationsCase Presentation on Diabetes Mellitus complications
Case Presentation on Diabetes Mellitus complications
 
Chronic calcific pancreatitis
Chronic calcific pancreatitisChronic calcific pancreatitis
Chronic calcific pancreatitis
 
Case membranous nephropathy
Case membranous nephropathyCase membranous nephropathy
Case membranous nephropathy
 
Mx of TB.pptx
Mx of TB.pptxMx of TB.pptx
Mx of TB.pptx
 
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...
 
Mr. Kannan
Mr. KannanMr. Kannan
Mr. Kannan
 
Case presentation on hemiplegia
Case presentation on hemiplegiaCase presentation on hemiplegia
Case presentation on hemiplegia
 
Effusions Explored
Effusions ExploredEffusions Explored
Effusions Explored
 
Effusions Explored
Effusions ExploredEffusions Explored
Effusions Explored
 

More from Dr. Afreen Nasir

A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
Dr. Afreen Nasir
 
PharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdfPharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdf
Dr. Afreen Nasir
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdf
Dr. Afreen Nasir
 
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdfTortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Dr. Afreen Nasir
 
Case Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx OncoCase Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx Onco
Dr. Afreen Nasir
 
Case Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx OncoCase Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx Onco
Dr. Afreen Nasir
 
Case Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx OncoCase Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx Onco
Dr. Afreen Nasir
 
Giudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdfGiudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdf
Dr. Afreen Nasir
 
Journal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of HemodialysisJournal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of Hemodialysis
Dr. Afreen Nasir
 
e poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdfe poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdf
Dr. Afreen Nasir
 
Case Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal MeningitisCase Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal Meningitis
Dr. Afreen Nasir
 
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHDCASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
Dr. Afreen Nasir
 
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTIONCASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
Dr. Afreen Nasir
 
Journal club on Drug Utilization Pattern in ICU
Journal club on Drug Utilization Pattern in ICUJournal club on Drug Utilization Pattern in ICU
Journal club on Drug Utilization Pattern in ICU
Dr. Afreen Nasir
 
Journal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdfJournal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdf
Dr. Afreen Nasir
 
A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...
Dr. Afreen Nasir
 
Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Case Presentation: Accelarated HTN, CKD, Bronchial asthama Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Dr. Afreen Nasir
 

More from Dr. Afreen Nasir (17)

A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
A Drug Utilization Evaluation of Bronchodilators Using a Defined Daily Dose M...
 
PharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdfPharmD Pharmacology 2 instruments name .pdf
PharmD Pharmacology 2 instruments name .pdf
 
Clinical pharmacy book by parthasarathi.pdf
Clinical pharmacy book by  parthasarathi.pdfClinical pharmacy book by  parthasarathi.pdf
Clinical pharmacy book by parthasarathi.pdf
 
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdfTortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
Tortora PRINCIPLES OF ANATOMY AND PHYSIOLOGY - Tortora - 14th Ed.pdf
 
Case Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx OncoCase Presentation: Extravasation.pptx Onco
Case Presentation: Extravasation.pptx Onco
 
Case Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx OncoCase Presentation: Cephalosporins.pptx Onco
Case Presentation: Cephalosporins.pptx Onco
 
Case Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx OncoCase Presentation: Aminoglycoside.pptx Onco
Case Presentation: Aminoglycoside.pptx Onco
 
Giudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdfGiudeline: Adverse event CTCAE version 5.pdf
Giudeline: Adverse event CTCAE version 5.pdf
 
Journal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of HemodialysisJournal club: Practice Pattern of Hemodialysis
Journal club: Practice Pattern of Hemodialysis
 
e poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdfe poster: Awareness on organ donation.pdf
e poster: Awareness on organ donation.pdf
 
Case Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal MeningitisCase Presentation: Cryptococcal Meningitis
Case Presentation: Cryptococcal Meningitis
 
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHDCASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
CASE PRESENTATION : T2DM , HTN, ACS/UA , HYPOTHYROIDISM ,IHD
 
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTIONCASE PRESENTATION:  UPPER RESIRATORY TRACT INFECTION
CASE PRESENTATION: UPPER RESIRATORY TRACT INFECTION
 
Journal club on Drug Utilization Pattern in ICU
Journal club on Drug Utilization Pattern in ICUJournal club on Drug Utilization Pattern in ICU
Journal club on Drug Utilization Pattern in ICU
 
Journal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdfJournal club on DUE of Corticosteroids.pdf
Journal club on DUE of Corticosteroids.pdf
 
A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...A study on drug utilisation evaluation of Bronchodilators using defined daily...
A study on drug utilisation evaluation of Bronchodilators using defined daily...
 
Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Case Presentation: Accelarated HTN, CKD, Bronchial asthama Case Presentation: Accelarated HTN, CKD, Bronchial asthama
Case Presentation: Accelarated HTN, CKD, Bronchial asthama
 

Recently uploaded

DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
patriciaava1998
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
ChetanSharma78255
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
MuzafarBohio
 
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdfU Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
Jokerwigs arts and craft
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
rightmanforbloodline
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
nirahealhty
 
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and EngagementPrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx Program
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
aditigupta1117
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
smuskaan0008
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
Arunima620542
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
DianaRodriguez639773
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
Vishal kr Thakur
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 

Recently uploaded (20)

DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
 
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdfU Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
U Part Wigs_ A Natural Look with Minimal Effort Jokerwigs.in.pdf
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
 
CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
 
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and EngagementPrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and Engagement
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
 
Hypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in itHypotension and role of physiotherapy in it
Hypotension and role of physiotherapy in it
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 

Case Presentation: MCTD , hypothyroidism ,hypertension, seizure disorder ( new onset , generalized tonic clonic seizure ) , cholelithiasis , microcytic hypochromic anemia of chronic disease with neutrophilia.

  • 2. PATIENT DEMOGRAPHY IP NO. : 101901765 Age/sex : 42 years female Department : unit M 1 Ward : 4th DOA : 21/10/19 DOD : 25/10/19
  • 3. COMPLAINTS ON ADMISSION • C/o high grade fever since 3 days , involuntary movement since 1 day , generalized weakness since morning, seizure 1 episode in morning , fever since yesterday. HISTORY OF PRESENT ILLNESS • H/o fever with regur , chill from past 3 days , headache since 3 days , associated with blurred vision • multiple joints pain since 6 years , deviation of angle of mouth ,ulceration in mouth • Bluish / black discolouration of digits on exposure to cold • Cheat pain , breathlessness , palpitation, cough yellowish sputum • H/o fall & LOC 2 hrs back , H/o 1 episode of GTCM today 23 min ago – attenders found her unconscious at 6 am . • H/o tongue bite +
  • 4. PATIENT HISTORY • Past medical history : Not K/C/O HTN , hypothyroidism ,k/c/o mixed connective tissue disorder since 6 years with Raynaud’s phenomenon. • Family history : Nothing significant • Medication history : • Social history : Diet – Mixed Sleep : N Appetite : N Bowel-Bladder : N • Allergy : NKA Drug Route Dose Frequency Duration Indication T. Methotrexate P/O Not specified Not specified Not specified Treat MCTD T. Prednisone P/O 10mg Once daily ’’ ’’
  • 5. GENERAL PHYSICAL EXAMNATION • Vital signs ( 21/10/19) BP: 150/90 mmHg HR : 100 bpm RR : 20 breaths/min SPO₂ : 99% RA • Patient is conscious oriented to T/P/P • PICCKLE : absent • Muscle tenderness + SYSTEMIC EXAMINATION (12:30 pm) CVS : S1S2 + CNS : drowsy , pupil : 2mm (both R &L ) , Patellar Tendon Reflex(PTR) : 2 + , HMF : + , Plantar :↓, Reflex : 2+ 2+ Power of both limbs : 5 5 Plantar B/L withdrawal 2+ 2+ 5 3/5 RS : B/L NVBS + PA : soft non tender
  • 7. LABORATORY EXAMINATION Tests performed 21/10/19 22/10/19 Normal values Hemogram Hgb 8.9 9.1 F= 12.3-15.5 g/dL PCV 28.5 29 F = 36-45% RBC 4.21 F = 3.5 – 4.5 × 10⁵ / mm³ Platelets 2.5 2.89 1.5-4.5 lakhs/mm³ Reticulocyte Count 0.321 0.5 – 2.5 % MCH 21 27-32 pg / cell MCV 70 80-96 fL MCHC 30 33 – 35.5 g/dL ESR 45 F= 1-20 mm /hr CRP 5.9 3 mg/L WBC 16000 10530 4000-11000/mm³ Neutrophils 90 89 45-73% Eosinophils 01 01 0-4% Lymphocytes 04 08 20-40%
  • 8. Tests performed 21/10/19 22/10/19 Normal values Basophils 00 00 0-1 % Monocytes 05 02 2-8% Folate 20.8 5 - 25 mcg/L Vit B12 134 180- 914 pg/ml Ferritin 21.7 F= 11-307 ng/ml Transferrin Saturation 6.47 20-50% Transferrin 289 200 – 300 mg/dL UIBC 313 112-346 microgram/dL TIBC 334 250-450 microgram/dL Sr.Iron 21.4 F= 37- 145 microgram / dL TFT TSH 1.81 0.25 – 6.7 milli unit /L FT3 1.38 2.3-4.1 pg/mL FT4 0.75 2.45 – 4.25 pg/ml LFT ALP 59 30-120 unit/L
  • 9. Tests performed 21/10/19 Normal values GGT 14 1-94 U/L Total bilirubin 0.4 Up to 1.2 mg/L Direct bilirubin 0.1 0.2 mg/dL SGOT/AST 29 10-35 U/L SGPT /ALT 26 <35 U/L Albumin 8.9 3.5-5.5g/dL Globulin 3.2 2.5-4.5 g/dL A/G ratio 1:1 1 – 5:1 T. Protein 6.7 6.6 – 8.7 g/dL RFT S. creatinine 0.9 F= 0.5-0.9 mg/dL BUN 2.9 7-20 mg/dl Sr. Sodium 134 136-145 mEq/L Sr .Potassium 3.4 3.5 – 5.1 mEq/L Sr. Chloride 102 97-114 mEq/L Sr. Calcium 8.3 8.5 – 10.5 mg/dL
  • 10. Tests performed 21/10/19 22/10/19 Normal values Biochemistry FBS 115 75-110 mg/dL LDH 28 F= 135 -214 U/L GRBS 133 108 <200 mg/dL
  • 11. FINAL DIAGNOSIS • Patient is diagnosed with MCTD , hypothyroidism ,hypertension, seizure disorder ( new onset , generalized tonic clonic seizure ) , cholelithiasis , microcytic hypochromic anemia of chronic disease with neutrophilia.
  • 12. TREATMENT GOALS • Patient specific – -Improve QOL -Selecting cost effective medicine & minimizing side effects of medicines • Disease specific – - Achieve normal thyroid function - Prevent progression of edema in brain before it damage brain - To bring electrolytes level to normal - To reduce breathlessness , chest pain , abdomen pain , body pain , headache - To normalize the raised body temp. - Reduce episodes of seizure.
  • 13. TREATMENT CHART Medicine prescribed Dose Freq Route 21/ 10 22/ 10 23/ 10 24/ 10 25/ 10 26/ 10 Indications T. Amlong ( AMLODIPINE) 5mg 0-0-1 P/O + + + + + + CCB: antihypertensive T. PREDNISOLONE 40mg 1-0-0 ’’ + + + + 60 mg 60 mg Treat breathlessness Inj. Dexoma (DEXAMETHASONE PHOSPHATE) 10mg/ ml 1-1-1 IV + + + + 1-0- 1 1-0- 1 Corticosteroid – treat cerebral edema Inj . PANTOPRAZOLE 40mg 1-0-0 IV + + + + 1-0- 1 80 mg 1-0- 1 80 mg PPI T. Thyronorm ( THYROXINE SODIUM) 50mcg 1-0-0 P/O + + + + + + Treat hypothyroidism T. SILDENAFIL 20mg 1-1-1 ’’ + + + + + + Treat Raynaud’s phenomena Inj. Xone (CEFTRIAXONE) 1g 1-0-1 IV + + + + + + Antibiotic for respiratory inf. Inj. MANNITOL 100ml 1-0-1 ’’ + + + + + + Diuretic – treat cerebral edema Inj. Levipil (LEVETIRACETAM) 500ml 1-1-1 ’’ + + + + + + Antiepileptic
  • 14. Medicine prescribed Dose Freq Route 21/ 10 22/ 10 23/ 10 24/ 10 25/ 10 26/ 10 Indications T. Chymoral Forte (TRYPSIN- CHYMOTRYPSIN) 1,00,000 armour units (T&C ratio 6:1) 1-0-1 P/O + + + Anti-inflammatory, analgesic T.CETIRIZINE 10mg 0-0-1 ’’ + + + Antihistimine T. FERROUS SULPHATE & FOLIC ACID 200mg / 5mg 1-0-1 ’’ + + + Iron & folic acid supplement to treat anemia Inj. VitB12 ( METHYLCOBALAMINE) 1500mcg OD IV + + + Vit B12 supplement to treat anemia T.Cal vitD3 (CALCIUM CARBONATE & CHOLECALCIFEROL) 250mg/12 5 IU 0-1-0 P/O + + Calcium supplement , treat hypothyroidism T. METHOTREXATE 15mg Once weekly P/O + Treat MCTD T. NAPROXEN 500mg Stat P/O + NSAID : Analgesic
  • 15. PROGRESS CHART Date Time PR (bpm) BP (mmHg) SPo2 % Notes Complaints 21/10 6 AM 1 epi GTCS ,lasting 2-3 min , LOC for 10 min, H/o tongue bite 12:30 pm 77 150/90 96 CVS : S1S2 + , RS: B/L NVBS + CNS: Pupil = 2mm both eyes , Plantar ↓ , PTR : 2+ 4:10 pm 90 ’’ 98 Pupil reactive , Muscle tenderness + Power of both limbs : 5 5 5 3/5 CT brain edema cerebral Reflex : 2+ 2+ 2+ 2+ Plantar B/L withdrawal 1 Epi seizure 22/10 132/80 98 RR: 20 breaths/min , Pupil reactive Plantar ↓ , Power of limbs 5 5 5 5
  • 16. Date PR (bpm) BP (mmHg) SPo2 % Notes Complaints 23/10 70 128/72 98 B/L pupil reactive , B/L plantar reflex Cytology report : CSF 2ml colourless clear , cell count = 02 cells/mm³ 24/10 68 110/80 98 RR: 20 breaths/min , Power : 5 5 5 5 Abdomen pain 25/10 69 110/70 97 Power : 5 5 5 5 26/10 68 120/70 98 RR: 18 breaths/m , CVS: S1S2 + non murmur , CNS : HMF +, Power of limbs : 5 5 5 5
  • 17. CLINICAL PHARMACIST NOTES / INTERVENTION Drug – drug interaction : • Contraindicated – Ceftriaxone + CaCO₃ • Serious(use alternatives) : Naproxen ↑level of MTX by ↓ renal clearance causes hematologic & GI toxicity • Monitor closely – - CaCO₃ ↓ effect of Amlodipine - Dexamethasone ↓ effect of Sildenafil , Prednisolone - Pantoprazole ↑level of MTX by ↓ renal clearance ADVICE TO DOCTOR: • Patient still has episodes of seizure which may further decrease Ca level in body , so can we include T. Calcium & Vit D3 in discharge medicine prescribed.
  • 18. DISCHARGE MEDICATION Medication prescribed Dose Frequency Route Duration Possible side effect T. PREDNISONE 60 mg 1-0-0 P/O 7 days Weight gain, allergies, vertigo T. Amlong ( AMLODIPINE) 5mg 1-0-1 ’’ ’’ Skin rash , abd pain , headache T. Levipil (LEVETIRACETAM) 500mg 1-1-1 ’’ ’’ Headache , lack of energy, fatigue T. METHOTREXATE 15mg Once weekly ’’ ↓appetite , gingivitis, skin redness T. SILDENAFIL 20mg 1-1-1 ’’ ’’ Headache , insomnia, dizziness T . PANTOPRAZOLE 40mg 1-0-0 ’’ ’’ Headache , abd pain ,facial edema,rash T. Thyronorm ( THYROXINE SODIUM) 50mcg 1-0-0 ’’ Irregular heart beat, anxiety , diarrhea T. FERROUS SULPHATE & FOLIC ACID 200mg / 5mg 1-0-1 ’’ Dark colour stool , constipation Zytee oral 10 ml gel ( CHOLINE SALICYLATE+ LIGNOCAINE HYDROCHLORIDE + BENZALKONIUM CHLORIDE) 9.0%w/v + 2.0%w/v + 0.02%w/ v Itching , burning
  • 19. PATIENT COUNSELLING • Disease • Medication • Diet • Lifestyle modification